Reference
FDA adds Boxed Warning for increased risk of severe hypocalcemia in patients with advanced chronic kidney disease taking osteoporosis medicine Prolia (denosumab) Internet Document : 19 Jan 2024. Available from: URL: https://www.fda.gov/drugs/drug-safety-and-availability/fda-adds-boxed-warning-increased-risk-severe-hypocalcemia-patients-advanced-chronic-kidney-disease
Rights and permissions
About this article
Cite this article
Boxed Warning on risk of severe hypocalcaemia with denosumab. Reactions Weekly 1992, 3 (2024). https://doi.org/10.1007/s40278-024-52736-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-024-52736-3